Japan Medical Dynamic Marketing, INC.
Notice Regarding Workforce Reduction and Other Rationalization Measures at U.S. Consolidated Subsidiary
Approximately 51 personnel reductions to be implemented at U.S. consolidated subsidiary ODEV. Retirement-related expenses expected to be recorded in the fiscal year ending March 2027; effects on fixed cost reductions to be examined. Continuation of ODEV's business operations is assumed.
Key Figures
- approx. 51 people (number of people affected)
- Retirement-related expenses expected to be recorded in the fiscal year ending March 2027
- ODEV equity ratio 99.4% (as of March 31, 2026)
AI要約
Overview
This notice announces a decision to implement workforce reductions at U.S. consolidated subsidiary Ortho Development Corporation (ODEV) to respond to changes in the business environment, aiming to reduce fixed costs through right-sizing the organization and improving operational efficiency. The reductions will target certain divisions of ODEV and are planned to affect approximately 51 people. This does not involve business withdrawal; functions necessary for continued operations such as product supply, quality, and regulatory affairs will be maintained.
Financial impact and outlook
Retirement-related expenses are expected to be recorded in the fiscal year ending March 2027. The personnel cost reduction effect for the same period and the impact from 2028 onwards are currently under review. If revisions to earnings guidance or other additional disclosures become necessary, they will be announced promptly.
Japan Medical Dynamic Marketing, INC.
Company overview · Stock price · Financial data · All IR
